not tagged
oncxerna therapeutics
['gastric', 'biomarker', 'marker ', 'oncxerna']
today at (esmo), we announced new xerna tme panel biomarker data from retrospective analysis of results from a randomized phase 2 trial evaluating anti-pd-1 maintenance therapy in esophagogastric adenocarcinoma. read more 
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel, targeted treatments. Improving lives of people with cancer.